| Nathan G Berger, MD | |
|
200 E 33rd St Ste 486, Baltimore, MD 21218-3322 | |
| (410) 554-2683 | |
| (410) 554-2900 |
| Full Name | Nathan G Berger |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 45 Years |
| Location | 200 E 33rd St Ste 486, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639148851 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VE0102X | Obstetrics & Gynecology - Reproductive Endocrinology | D0023905 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Agnes Hospital | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Seton Medical Group Inc | 7416037924 | 75 |
News Archive
Inovio Pharmaceuticals, Inc. announced today that its SynCon avian influenza vaccine generated protective HAI titers against six different unmatched strains of H5N1 in a phase I clinical trial - a distinct clinical achievement on Inovio's path to develop universal influenza vaccines.
U.S. Food and Drug Administration (FDA) researchers say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects.
Canadian women will soon be able to access the first vaccine to protect against the sexually transmitted virus that causes cervical cancer.
The non-steroidal anti-inflammatory drug meloxicam significantly improves nighttime physical activity in cats with osteoarthritis, indicating its potential as a pain reliever in this feline population, report Canadian researchers.
Pfizer Inc. today announced that it has started a Phase 1/2 trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adult volunteers. RSV is a common respiratory virus that affects the lungs and airways, with significant impact on young children and older adults.
› Verified 3 days ago
| Entity Name | Seton Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144409194 PECOS PAC ID: 7416037924 Enrollment ID: O20080122000384 |
News Archive
Inovio Pharmaceuticals, Inc. announced today that its SynCon avian influenza vaccine generated protective HAI titers against six different unmatched strains of H5N1 in a phase I clinical trial - a distinct clinical achievement on Inovio's path to develop universal influenza vaccines.
U.S. Food and Drug Administration (FDA) researchers say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects.
Canadian women will soon be able to access the first vaccine to protect against the sexually transmitted virus that causes cervical cancer.
The non-steroidal anti-inflammatory drug meloxicam significantly improves nighttime physical activity in cats with osteoarthritis, indicating its potential as a pain reliever in this feline population, report Canadian researchers.
Pfizer Inc. today announced that it has started a Phase 1/2 trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adult volunteers. RSV is a common respiratory virus that affects the lungs and airways, with significant impact on young children and older adults.
› Verified 3 days ago
| Entity Name | Medstar Medical Group Ii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000347 |
News Archive
Inovio Pharmaceuticals, Inc. announced today that its SynCon avian influenza vaccine generated protective HAI titers against six different unmatched strains of H5N1 in a phase I clinical trial - a distinct clinical achievement on Inovio's path to develop universal influenza vaccines.
U.S. Food and Drug Administration (FDA) researchers say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects.
Canadian women will soon be able to access the first vaccine to protect against the sexually transmitted virus that causes cervical cancer.
The non-steroidal anti-inflammatory drug meloxicam significantly improves nighttime physical activity in cats with osteoarthritis, indicating its potential as a pain reliever in this feline population, report Canadian researchers.
Pfizer Inc. today announced that it has started a Phase 1/2 trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adult volunteers. RSV is a common respiratory virus that affects the lungs and airways, with significant impact on young children and older adults.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nathan G Berger, MD 200 E 33rd St Ste 486, Baltimore, MD 21218-3322 Ph: (410) 554-2683 | Nathan G Berger, MD 200 E 33rd St Ste 486, Baltimore, MD 21218-3322 Ph: (410) 554-2683 |
News Archive
Inovio Pharmaceuticals, Inc. announced today that its SynCon avian influenza vaccine generated protective HAI titers against six different unmatched strains of H5N1 in a phase I clinical trial - a distinct clinical achievement on Inovio's path to develop universal influenza vaccines.
U.S. Food and Drug Administration (FDA) researchers say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects.
Canadian women will soon be able to access the first vaccine to protect against the sexually transmitted virus that causes cervical cancer.
The non-steroidal anti-inflammatory drug meloxicam significantly improves nighttime physical activity in cats with osteoarthritis, indicating its potential as a pain reliever in this feline population, report Canadian researchers.
Pfizer Inc. today announced that it has started a Phase 1/2 trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adult volunteers. RSV is a common respiratory virus that affects the lungs and airways, with significant impact on young children and older adults.
› Verified 3 days ago
Miss Elizabeth Unique Morris, MSN, WHNP-BC Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 330 N Howard St, Baltimore, MD 21201 Phone: 410-576-1414 | |
Christine E. O Connor, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 227 Saint Paul St, 6th Floor, Baltimore, MD 21202 Phone: 410-332-9002 Fax: 410-783-5880 | |
Amara Chinyere Unegbu-ogbonna, PA-C Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 345 St. Paul Place, Bunting Building - Department Of Ob/gyn, Baltimore, MD 21202 Phone: 410-332-9000 | |
Fateh Hraky Sr., Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3001 S Hanover St, Suite 301, Baltimore, MD 21225 Phone: 410-350-0800 | |
Joyce A Bonsu, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3449 Wilkens Ave Ste 305, Baltimore, MD 21229 Phone: 410-644-2582 Fax: 410-644-6232 | |
Fouad M Abbas, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2411 W Belvedere Ave, Suite 206, Baltimore, MD 21215 Phone: 410-601-9030 | |
Dr. Ginny M Merryman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6569 N Charles St, Suite 501, Baltimore, MD 21204 Phone: 410-938-8960 Fax: 410-583-9770 |